The Association for Accessible Medicines (AAM), a trade association for major pharmaceutical manufacturers such as 3M, is drafting a letter to send to President Trump opposing his proposed ‘Buy American’ executive order reshoring medical supply chains. The letter currently has over 40 signatories, including PhRMA, a Big Pharma lobbying organization, dozens of medical nonprofits, and free market-oriented organizations, indicating the president will face immense pressure across the political spectrum for trying to reduce US medical dependence on China.
H/T: Spectator USA
From the letter obtained by The Spectator:
Proposals to drive all manufacturing to the United States not only overestimate the potential feasibility and underestimate the time and effort it would take to make such changes, but also misunderstand that a diverse pharmaceutical supply chain is precisely what enables the industry to respond quickly and make adjustments in its supply chain sourcing during natural emergencies and global public health crises.
U.S. business groups warn 'Buy America' order would harm pandemic response https://t.co/uIboKSjgzo— DeepClips (@DeepClips) March 27, 2020
Let this sink in for 1 min: Big Pharma, healthcare lobby & the globalist free trade groups caused the problem of medical device and supply & drug, shortages w/ their offshoring advocacy&practices b4 Now they r in high gear 2 prevent fixing that problem. 🤦🏻♂️https://t.co/CdaCIM1Rpy— CPA (@cpa_tradereform) March 26, 2020